Takeda Pharmaceutical Co Ltd (FRA:TKD)
€ 25.61 0.16 (0.63%) Market Cap: 40.44 Bil Enterprise Value: 65.50 Bil PE Ratio: 23.27 PB Ratio: 0.97 GF Score: 82/100

Takeda Pharmaceutical Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 12:30AM GMT
Release Date Price: €25.2 (-1.18%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Hello. Good evening and good morning. I'm James Gordon, JPMorgan Pharma and Biotech analyst and today, at the JPMorgan conference, have the pleasure of introducing the Takeda presentation and hosting the Q&A. So we have Takeda President and CEO, Christophe Weber, joining us for this 20-minute presentation. And then we can have other members of Takeda management joining us for the Q&A afterwards. And I'm looking forward to the presentation a lot, so over to you, Christophe.

Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director

Thank you, James. Hello, everyone. Thank you all for joining us today. While many of us, we are looking forward to gathering in San Francisco for the annual conference and yet COVID-19 continues to put the world on notice as we still have a long road ahead of us. The latest development in this devastating pandemic continued to remind us of the importance of our work for patients and society. But I'm

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot